Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1976
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976
Report date:
1976

Materials and methods

Principles of method if other than guideline:
A single dose of the test substance dissolved in the appropriate vehicle was injected in to the peritoneal cavity of the test animals. After application, the animals were observed for mortality and clinical signs of toxicity. Animals that died during the experiment were necropsied. Surviving animals were sacrificed 14 days after application for the purpose of necropsy.

GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
3,10-bis(2-methylpropyl) perylene-3,10-dicarboxylate; 3,9-bis(2-methylpropyl) perylene-3,9-dicarboxylate
EC Number:
616-749-7
Cas Number:
79869-59-3
Molecular formula:
C30H28O4
IUPAC Name:
3,10-bis(2-methylpropyl) perylene-3,10-dicarboxylate; 3,9-bis(2-methylpropyl) perylene-3,9-dicarboxylate
Details on test material:
- Analytical purity: 100%
- Name of test material (as cited in study report): Fluorolgruengold Misch. Nr. 27-3887

Test animals

Species:
mouse
Strain:
other: NMRI ivanovas
Sex:
male/female

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
CMC (carboxymethyl cellulose)
Details on exposure:
- Concentration in vehicle: 30% in 0.5% CMC
Doses:
4640 and 6810 mg/kg
higher concentration could not be tested because of technical reasons
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 6 810
Remarks on result:
other: No mortality occurred
Mortality:
4640 mg/kg bw: 0/5 M, 0/5 F
6810 mg/kg bw: 0/5 M, 0/5 F
Clinical signs:
Dyspnoe, apathy, spastic gait, tonic convulsions, poor general state of health
Body weight:
normal weight increase.
males: 26.0 g
females: 24.0 g
Gross pathology:
intra amdominal residues of the test article

Applicant's summary and conclusion